IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Emcure Pharmaceuticals IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 1952.03 Cr. The company is based in Pune and caters to Pharmaceutical sector. Axis Capital , J.P. Morgan India , Jefferies India , Kotak Mahindra Capital Company are the merchant bankers of Emcure Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th December 2023.
Emcure Pharmaceuticals IPO open date is 3rd July 2024 and close date is 5th July 2024. IPO Allotment Date is 8th July 2024 and Listing date is 10th July 2024.
IPO
Size:
₹ 1952.03 Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Axis Capital
IPO by BRLM so far:
161
City:
Pune
IPO so far:
19
Revenue (annualised):
₹
6715.24
cr. 
PE
Ratio:
36.07x
Average Sector PE Ratio: 25.12x
Emcure Pharmaceuticals IPO size is ₹ 1952.03 Cr. with IPO price of ₹ 1008.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Axis Capital Limited is the book-running lead manager of the Emcure Pharmaceuticals IPO. Link Intime India Private Limited is the Registrar for Emcure Pharmaceuticals IPO.
Emcure Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Emcure Pharmaceuticals IPO, based in Pune, operates in the Pharmaceutical sector with a focus on broad range of pharma. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Emcure Pharmaceuticals IPO size is ₹ 1952.03 Cr. with fresh issue size of ₹ 800.00 Cr. and Offer for sale being ₹ 1152.03Cr.
The IPO allotment date for Emcure Pharmaceuticals IPO is expected to be 8th July 2024, after the finalization of basis of allotment. Investors can check Emcure Pharmaceuticals IPO allotment status on the registrars website, Link Intime India Private Limited . Emcure Pharmaceuticals IPO refund dates are 9th July 2024.
Emcure Pharmaceuticals IPO is expected to be listed on 10th July 2024.
The upper price band for the Emcure Pharmaceuticals IPO is set at ₹ 1008.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Emcure Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Emcure Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 5th July 2024. After submission, funds are blocked until the basis of allotment of Emcure Pharmaceuticals IPO is finalised.
The merchant banker for Emcure Pharmaceuticals IPO is Axis Capital Limited , J.P. Morgan India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited . Axis Capital Limited , J.P. Morgan India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Emcure Pharmaceuticals IPO RHP for further details.
The registrar for Emcure Pharmaceuticals IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Emcure Pharmaceuticals IPO through their official website or helpline.
Emcure Pharmaceuticals IPO was subscribed 67.87 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 1952.03 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Axis Capital
IPO by BRLM so far:
161
City:
Pune
IPO so far:
19
Revenue (annualised):
₹ 6,658.25 cr.
PE
Ratio:
36.07x
Average Sector PE Ratio: 25.12x
Emcure Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Emcure Pharmaceuticals Financial Review Page
Merchant Banker(s) of Emcure Pharmaceuticals IPO: Axis Capital Limited , J.P. Morgan India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Emcure Pharmaceuticals IPO subscription was 67.87 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Emcure Pharmaceuticals IPO listed at a listing price of 1358.85 against the offer price of 1008.00.
The current market price of Emcure Pharmaceuticals is 1327.40.
Why Us?
